我院新冠肺炎疫情期间发热门诊隔离区用药处方及抗菌药物使用情况分析

中国医药导刊 ›› 2021, Vol. 23 ›› Issue (12): 952-955.

我院新冠肺炎疫情期间发热门诊隔离区用药处方及抗菌药物使用情况分析

陈娟娟1，王松1，姚明解2，张菡1，王彦芳1，李增1，张英杰1，杜书章1*

1.郑州大学第一附属医院药学部，河南郑州 450052； 2.北京大学基础医学院人体解剖学与组织胚胎学系，北京 100191

收稿日期:2021-06-04 修回日期:2021-09-17 出版日期:2021-12-28 发布日期:2021-12-28
基金资助:
国家自然科学基金青年科学基金项目(项目编号：81902115；项目名称：胆汁酸通过激活NF-κB途径及破坏高尔基体结构上调肝纤维化/肝硬化患者血清GP73水平的机制研究)；郑州大学第一附属医院院内青年创新基金项目（项目编号:15110502；项目名称：医院药房信息化平台建设）

Analysis of Drug Prescriptions and Use of Antimicrobial Agents in the Isolation Area of Fever Clinic in Our Hospital during COVID-19 Pandemic

1. Department of Pharmacy, the First Affiliated Hospital of Zhengzhou University, Henan Zhengzhou 450052, China; 2. Department of Anatomy and Embryology, School of Basic Medical Science, Peking University Health Science Center, Beijing 100191, China

Received:2021-06-04 Revised:2021-09-17 Online:2021-12-28 Published:2021-12-28

摘要/Abstract

摘要： 目的:分析我院新冠肺炎（COVID-19）疫情期间发热门诊隔离区用药处方及抗菌药物的使用情况，为发热门诊隔离区的药品供应及抗菌药物的应用提供参考。方法：收集我院COVID-19疫情期间发热门诊隔离区用药处方，依据卫生行政部门制定的处方评价表进行分析，采用WHO推荐的限定日剂量(DDD)分析法，结合药物利用指数（DUI）对含抗菌药物的处方进行统计和分析。结果：COVID-19疫情期间，我院发热门诊隔离区患者所用药品共5类15种，以抗感染、抗病毒、解热镇痛类药物为主，其中抗菌药物共6种，使用频次占比为43.89%；发热门诊隔离区处方的抗菌药物使用率为56.07%，无抗菌药物联合应用情况；其中DUI≤1的抗菌药物4种，占比66.67%，DUI＞1的抗菌药物2种，占比33.33%。结论：COVID-19疫情期间，发热门诊隔离区建议至少配备抗感染、抗病毒、解热镇痛、消化系统用药等药物。我院COVID-19疫情期间发热门诊隔离区抗菌药物的联合使用情况、DDDs、DUI均在较为合理的范围，但存在抗菌药物使用率偏高、选择倾向大及超剂量使用的情况，故建议临床医生在药物治疗过程中合理使用药物，同时做好药学监护，以保证患者用药安全。

关键词: font-size:medium, ">发热门诊；处方分析；抗菌药物

Abstract: Objective:To analyze the drug prescriptions and use of antimicrobial agents in the isolation area of fever clinic in our hospital during COVID-19 pandemic, and to provide reference for the drug supply and use of antimicrobial agents in the isolation area of fever clinic. Methods:The drug prescriptions in the isolation area of fever clinic in our hospital during COVID-19 pandemic were collected and analyzed according to the prescription evaluation table developed by the health administrative department. The defined daily dose(DDD) method recommended by WHO and drug utilization index(DUI) were used to statistically analyze the prescriptions containing antimicrobial agents. Results: During the COVID-19 pandemic, 15 kinds of drugs in 5 categories were used in the isolation area of fever clinic in our hospital,which inclued 6 kinds of antimicrobial agents. The use frequency of antimicrobial agents accounted for 43.89%. The usage rate of antimicrobial agents in the isolation area of fever clinic was 56.07%, and no combined use of antimicrobial agents. There were 4 kinds of antimicrobial agents with DUI≤1, accounting for 66.67%. There were 2 kinds of antimicrobial agents with DUI>1, accounting for 33.33%. Conclusion: During COVID-19 pandemic, it is recommended that at least anti-infection, antiviral, antipyretic and analgesic, and digestive system drugs should be equipped in the isolation area of fever clinic. The combined use, DDDs and DUI of antimicrobial agents in the isolation area of fever clinic in our hospital during COVID-19 pandemic were in a reasonable range, however, the usage rate and the tendency of selecting antimicrobial agents were relatively high, and overdose use of antimicrobial agents existed. Therefore, it is suggested that clinicians should use drugs rationally in the process of drug therapy, and pharmaceutical care should be conducted to ensure safe medication for the patients.

Key words: Fever clinic, Prescription analysis, Antimicrobial agents

中图分类号:

陈娟娟, 王松, 姚明解, 张菡, 王彦芳, 李增, 张英杰, 杜书章. 我院新冠肺炎疫情期间发热门诊隔离区用药处方及抗菌药物使用情况分析[J]. 中国医药导刊, 2021, 23(12): 952-955.

CHEN Juanjuan, WANG Song, Yao Mingjie, ZHANG Han, WANG Yanfang, LI Zeng, ZHANG Yingjie, DU Shuzhang. Analysis of Drug Prescriptions and Use of Antimicrobial Agents in the Isolation Area of Fever Clinic in Our Hospital during COVID-19 Pandemic[J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2021, 23(12): 952-955.

参考文献

[1]WHO. Director-General′s remarks at the media briefing on 2019 novel coronavirus on 8 February 2020[EB/OL].(2020-02-08) [2020-06-15]. https://www.who.int/dg/speeches/detail/director-general-s-remarks-at-the-media-briefing-on-2019-novel-coronavirus-8-february-2020.
     [2]白浪,王铭,唐小琼,等. 对新型冠状病毒肺炎诊疗中的热点问题的思考[J].华西医学, 2020, 35(2): 125-131.
     [3]国家卫生健康委办公厅, 国家中医药管理局办公室. 新型冠状病毒肺炎诊疗方案（试行第八版修订版）[EB/OL].(2021-04-15) [2021-05-23].http://www.nhc.gov.cn/yzygj/s7653p/202104/7de0b3837c8b4606a0594a eb0105232b.shtml.
     [4]国务院应对新型冠状病毒感染的肺炎疫情联防联控机制.关于印发近期防控新型冠状病毒感染的肺炎工作方案的通知（肺炎机制发〔2020〕9号）[EB/OL].(2020-01-28) [2020-06-15]. http://www.nhc.gov.cn/tigs/s7848/202001/808bbf75e5ce415aa19f74c78ddc653f.shtml.
     [5]彭志洋,闫瑞承,刘家盛,等. 发热门诊对新型冠状病毒肺炎规范化防控与诊治[J].武汉大学学报(医学版),2020,41(3): 388-391.
     [6]胡立强,熊青云,李燕,等. 新型冠状病毒肺炎定点医院发热门诊规范化管理探索[J].中国医院管理, 2020, 40(4): 47-50.
     [7]吴静,黎杨芬,雷光华,等. 大型综合医院新型冠状病毒肺炎防控工作实践与体会[J].中国感染控制杂志, 2020, 19(4): 293-296.
     [8]原卫生部.处方管理办法（中华人民共和国卫生部令第53号）[EB/OL].(2006-02-14) [2021-09-15]. http://www.nhc.gov.cn/yzygj/s3572/200602/dd4277bbf3784ff589b9f12b6a0422ab.shtml.
     [9]乔亚楠,王欣春,刘海宇,等. 山西医科大学第二医院门诊西药房处方点评及不合理处方分析[J].中国药事, 2018, 32(3): 394-398.
     [10]谢娴婷,董卫华,尤海生,等. 某院门急诊抗菌药物处方点评效果评价[J].中国药房, 2016, 27(8): 1041-1044.
     [11]马嘉,陈盛新,裘雪友. 医院开展药物利用研究的基本概念和方法[J].中国药学杂志, 1999, 34(10): 706-708.
     [12]陈元成. 综合性三级医院门急诊抗菌药物的用药分析[J].中华医院感染学杂志, 2011, 21(23): 5041-5043.
     [13]卢圆圆,李伟杰,刘东,等. 新冠肺炎疫情期间发热门诊处方分析[J].中国医院药学杂志, 2020,40（12），1296-1299，1338.
     [14]原国家卫生和计划生育委员会办公厅. 2013年全国抗菌药物临床应用专项整治活动方案[EB/OL].(2013-05-07)[2021-09-15]. http://www.nhc.gov.cn/yzygj/s3585u/201305/823b9d131ff4416ab7b41b2c4e1f0e83.shtml.
     [15]谢娴婷,董卫华,尤海生,等. 某院门急诊抗菌药物处方点评效果评价[J].中国药房, 2016, 27(8): 1041-1044.
     [16]李俊峰,刘建军. 合肥市第二人民医院门急诊抗菌药物处方分析点评[J].中国药事, 2015, 29(6): 666-671.
     [17]张洪标,张传福,李燕平,等. 中山市第三人民医院2018年门诊第二类精神药品使用趋势分析[J]. 中国实用医药, 2020, 15(16): 159-161.
     [18]朱蕊,刘蕊. 我院门急诊麻醉药品使用情况分析[J]. 中国医药导刊, 2021, 23(5): 360-363.
     [19]袁冬冬,陈永妍,王本军,等. 新型冠状病毒肺炎疫情防控下发热调剂室的药学实践[J].中国医院药学杂志, 2020, 40(8): 869-872.
     [20]胡位,姜云云,吴晏玲,等. 新型冠状病毒肺炎疫情期间医院发热门诊用药分析[J].中国药业, 2020, 29(10): 54-56.
     [21]沈爱宗,吴颖其,张圣雨,等. 新型冠状病毒肺炎疫情下门诊药品调剂中心防控策略与药学服务[J].中国医院药学杂志, 2020, 40(15): 1603-1606.

快速检索引用检索图表检索高级检索